Physician

Jean-Raphael Schneider, M.D.

According to 2025 Medicare claims, Jean-Raphael Schneider, M.D. (NPI: 1487691127) practices neurology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is MS & NEUROMUSCULAR CENTER OF EXCELLENCE LLC (NPI: 1821480419; TIN: 472965904) and primary practice location at 33761-2013.

Schneider's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 961 traditional Medicare patients, billed 162,101 HCPCS/CPT codes, and received $5,156,804 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 2,161 prescription claims across 385 beneficiaries totaling $5,024,896 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 24 claims. Open Payments data shows 258 records totaling $598,247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $375,570 to $5,156,804. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,536,189 and ending at $5,024,896. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $48,322 and ending at $3,318.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	575	8,228	$375,570
2016	701	19,097	$776,290
2017	694	25,672	$1,035,460
2018	786	42,817	$2,753,327
2019	822	46,912	$2,542,043
2020	790	47,107	$2,595,765
2021	816	61,944	$2,965,667
2022	845	88,415	$3,766,608
2023	1,003	130,242	$4,473,973
2024	961	162,101	$5,156,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	309	2,541	$3,536,189
2016	305	2,440	$3,279,062
2017	315	2,591	$4,444,128
2018	386	2,681	$5,320,542
2019	393	2,758	$5,924,924
2020	422	3,068	$6,138,327
2021	411	2,803	$4,912,599
2022	387	2,396	$4,959,410
2023	366	2,063	$3,289,412
2024	385	2,161	$5,024,896

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$3,930
2016	N/R	11	$3,337
2017	11	35	$4,188
2018	N/R	62	$4,963
2019	N/R	53	$4,874
2020	N/R	12	$4,002
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$579

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	127	128	$152
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	199	199	$152
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	441	626	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	408	579	$90
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	190	381	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	92	2,185	$1,279,060
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	60	1,328	$1,080,643
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	61	1,403	$651,982
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	23	484	$261,388
Radicava Ors	Edaravone	16	448	$226,287

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	12	$428
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	12	$151

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	227	$24,263	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	31	$573,984	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jean-Raphael Schneider, M.D.?

Tedicare shows public-source Medicare data for Jean-Raphael Schneider, M.D. (NPI 1487691127), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jean-Raphael Schneider, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jean-Raphael Schneider, M.D.?

Jean-Raphael Schneider, M.D. is linked to MS & NEUROMUSCULAR CENTER OF EXCELLENCE LLC (billing NPI 1821480419) in the available physician profile data.

Does Jean-Raphael Schneider, M.D. have Open Payments data?

Jean-Raphael Schneider, M.D. has 258 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.